Effects of Resistance Training on Substrate Metabolism During the Menstrual Cycle
NCT ID: NCT04024826
Last Updated: 2021-10-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
10 participants
INTERVENTIONAL
2019-07-01
2020-03-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Resistance Training in Body Composition and Body Image Perception of Women Throughout the Menstrual Cycle
NCT04038463
Resistance Training and Sex Hormone Concentrations During the Menstrual Cycle
NCT04163380
Menstrual Cycle Phase Based Training
NCT05936424
Biomechanical Changes During Menstrual Cycle
NCT03979326
Effect of Video-based Exercise on Premenstrual Symptoms: a Randomized Controlled Trial
NCT05998044
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early Follicular Phase (EFP)
This group is comprised of participants at the Early Follicular Phase (EFP) of the menstrual cycle.
EFP
This group will perform the Resistance training intervention on day 4 of the menstrual cycle, which corresponds to the mid of early follicular phase.
Late Follicular Phase
This group is comprised of participants at the Late Follicular Phase (LFP) of the menstrual cycle.
LFP
This group will perform the Resistance training intervention on day 11 of the menstrual cycle, which corresponds to the mid of late follicular phase.
Early Luteal Phase
This group is comprised of participants at the Early Luteal Phase (ELP) of the menstrual cycle.
ELP
This group will perform the Resistance training intervention on the day 18 of the menstrual cycle, which corresponds to the mid of early luteal phase
Late Luteal Phase
This group is comprised of participants at the Late Luteal Phase(LLP) of the menstrual cycle.
LLP
This group will perform the Resistance training intervention on day 21 of the menstrual cycle, which corresponds to the mid of late luteal phase
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EFP
This group will perform the Resistance training intervention on day 4 of the menstrual cycle, which corresponds to the mid of early follicular phase.
LFP
This group will perform the Resistance training intervention on day 11 of the menstrual cycle, which corresponds to the mid of late follicular phase.
ELP
This group will perform the Resistance training intervention on the day 18 of the menstrual cycle, which corresponds to the mid of early luteal phase
LLP
This group will perform the Resistance training intervention on day 21 of the menstrual cycle, which corresponds to the mid of late luteal phase
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Including higher BMI participants might alter the results as increased body fat has been linked to changes in different hormonal levels (not only sex hormones) and that might influence substrate utilization.
* Sedentary .or physically active for 2 days a week or less.
Exclusion Criteria
* cardio-respiratory conditions,
* metabolic conditions,
* irregular menstrual cycle,
* menstrual dysfunction or unusual sex hormone levels,
* on contraceptives,
* on medication that alter hormonal or cardio-respiratory responses,
* pre-menopausal symptoms,
* on moderate to high-intensity exercise regime more than 2d/week.
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Southern Illinois University Edwardsville
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria Fernandez del Valle, PhD
Role: PRINCIPAL_INVESTIGATOR
Southern Illinois University Edwardsville
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Southern Illinois University Edwardsville
Edwardsville, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
111A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.